AI in Healthcare Thematic Intelligence Research Report 2024 Featuring AstraZeneca, BMS, Eli Lilly, GSK, Johnson Johnson, Novartis, Pfizer, Roche, Sanofi, 3M, GE Healthcare, Philips, and Zimmer Biomet
TLVCX Fund | USD 16.02 0.07 0.44% |
Slightly above 55% of Timothy Largemid's investor base is interested to short. The analysis of overall sentiment of trading Timothy Largemid Cap Value mutual fund suggests that many investors are impartial at this time. Timothy Largemid's investing sentiment can be driven by a variety of factors including economic data, Timothy Largemid's earnings reports, geopolitical events, and overall market trends.
Timothy |
Dublin, Dec. 04, 2024 -- The AI in Healthcare - Thematic Intelligence report has been added to ResearchAndMarkets.coms offering. Demand for AI consulting and support services and conversational platforms will drive market growth, bolstered by the adoption and increased interest in generative AI .AI is an essential technology for healthcare companies. In the pharma and medical devices industry, AI rapidly accelerates drug discovery and manufacturing and enables supply c
Read at finance.yahoo.com
Timothy Largemid Fundamental Analysis
We analyze Timothy Largemid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Timothy Largemid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Timothy Largemid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Timothy Largemid is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Timothy Largemid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Timothy Largemid mutual fund to make a market-neutral strategy. Peer analysis of Timothy Largemid could also be used in its relative valuation, which is a method of valuing Timothy Largemid by comparing valuation metrics with similar companies.
Peers
Timothy Largemid Related Equities
TLGCX | Timothy Largemip | 0.44 | ||||
TIAGX | Timothy Aggressive | 0.07 | ||||
TIICX | Timothy Plan | 0.19 | ||||
TISGX | Timothy Plan | 0.20 | ||||
TGIAX | Timothy Plan | 0.37 | ||||
TFIAX | Timothy Fixed | 0.44 | ||||
TFICX | Timothy Fixed | 0.46 | ||||
TIGIX | Timothy Plan | 0.46 | ||||
TGCIX | Timothy Plan | 0.48 | ||||
TICIX | Timothy Israel | 0.63 |
Other Information on Investing in Timothy Mutual Fund
Timothy Largemid financial ratios help investors to determine whether Timothy Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Timothy with respect to the benefits of owning Timothy Largemid security.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |